A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study

There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European count...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 45; no. 21; pp. 1904 - 1916
Main Authors Frank, Derk, Durand, Eric, Lauck, Sandra, Muir, Douglas F, Spence, Mark, Vasa-Nicotera, Mariuca, Wood, David, Saia, Francesco, Urbano-Carrillo, Cristóbal A, Bouchayer, Damien, Iliescu, Vlad Anton, Saint Etienne, Christophe, Leclercq, Florence, Auffret, Vincent, Asmarats, Lluis, Di Mario, Carlo, Veugeois, Aurelie, Maly, Jiri, Schober, Andreas, Nombela-Franco, Luis, Werner, Nikos, Gómez-Hospital, Joan Antoni, Mascherbauer, Julia, Musumeci, Giuseppe, Meneveau, Nicolas, Meurice, Thibaud, Mahfoud, Felix, De Marco, Federico, Seidler, Tim, Leuschner, Florian, Joly, Patrick, Collet, Jean-Philippe, Vogt, Ferdinand, Di Lorenzo, Emilio, Kuhn, Elmar, Disdier, Vicente Peral, Hachaturyan, Violetta, Lüske, Claudia M, Rakova, Radka, Wesselink, Wilbert, Kurucova, Jana, Bramlage, Peter, McCalmont, Gemma
Format Journal Article
LanguageEnglish
Published England Oxford University Press (OUP) 01.06.2024
Oxford University Press
Subjects
Aged
Aged, 80 and over
Aortic Valve Stenosis - surgery
Benchmarking
Bioengineering
Clinical Research
Critical Pathways
Europe - epidemiology
Female
Humans
Length of Stay - statistics & numerical data
Life Sciences
Male
Patient Safety
Postoperative Complications - epidemiology
Postoperative Complications - prevention & control
Transcatheter Aortic Valve Replacement - methods
Europe
Aortic stenosis
Transcatheter aortic valve implantation
Prospective registry
Health services
TAVI
Clinical care
Quality of care
Online AccessGet full text

Cover

Abstract There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries. This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety. Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%). Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.
AbstractList Structured Graphical Abstract BENCHMARK: streamlined transcatheter aortic valve implantation (TAVI) pathway with retained safety. CCU, coronary care unit; ICU, intensive care unit; GW, general ward; IMC, intermediate care; PPM, permanent pacemaker. *Includes patients with available data on LoS only.
There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries.BACKGROUND AND AIMSThere is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries.This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety.METHODSThis was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety.Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%).RESULTSBetween January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%).Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.CONCLUSIONSBroad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.
Abstract Background and Aims There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries. Methods This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety. Results Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%). Conclusions Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.
BACKGROUND AND AIMS: There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries. METHODS: This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety. RESULTS: Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%). CONCLUSIONS: Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.
There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this study was to evaluate the effect of implementing BENCHMARK best practices on the efficiency and safety of TAVI in 28 sites in 7 European countries. This was a study of patients with severe symptomatic aortic stenosis (AS) undergoing TAVI with balloon-expandable valves before and after implementation of BENCHMARK best practices. Principal objectives were to reduce hospital length of stay (LoS) and duration of intensive care stay. Secondary objective was to document patient safety. Between January 2020 and March 2023, 897 patients were documented prior to and 1491 patients after the implementation of BENCHMARK practices. Patient characteristics were consistent with a known older TAVI population and only minor differences. Mean LoS was reduced from 7.7 ± 7.0 to 5.8 ± 5.6 days (median 6 vs. 4 days; P < .001). Duration of intensive care was reduced from 1.8 to 1.3 days (median 1.1 vs. 0.9 days; P < .001). Adoption of peri-procedure best practices led to increased use of local anaesthesia (96.1% vs. 84.3%; P < .001) and decreased procedure (median 47 vs. 60 min; P < .001) and intervention times (85 vs. 95 min; P < .001). Thirty-day patient safety did not appear to be compromised with no differences in all-cause mortality (0.6% in both groups combined), stroke/transient ischaemic attack (1.4%), life-threatening bleeding (1.3%), stage 2/3 acute kidney injury (0.7%), and valve-related readmission (1.2%). Broad implementation of BENCHMARK practices contributes to improving efficiency of TAVI pathway reducing LoS and costs without compromising patient safety.
Author Mascherbauer, Julia
Iliescu, Vlad Anton
Veugeois, Aurelie
Spence, Mark
Meurice, Thibaud
Lauck, Sandra
Rakova, Radka
Saia, Francesco
Di Mario, Carlo
Leuschner, Florian
Hachaturyan, Violetta
Di Lorenzo, Emilio
Nombela-Franco, Luis
Maly, Jiri
Werner, Nikos
Lüske, Claudia M
De Marco, Federico
Seidler, Tim
Frank, Derk
Saint Etienne, Christophe
Vogt, Ferdinand
Asmarats, Lluis
Wesselink, Wilbert
McCalmont, Gemma
Leclercq, Florence
Auffret, Vincent
Mahfoud, Felix
Joly, Patrick
Urbano-Carrillo, Cristóbal A
Durand, Eric
Musumeci, Giuseppe
Kurucova, Jana
Vasa-Nicotera, Mariuca
Bouchayer, Damien
Meneveau, Nicolas
Wood, David
Schober, Andreas
Kuhn, Elmar
Bramlage, Peter
Collet, Jean-Philippe
Disdier, Vicente Peral
Muir, Douglas F
Gómez-Hospital, Joan Antoni
Author_xml – sequence: 1
  givenname: Derk
  orcidid: 0000-0001-7561-075X
  surname: Frank
  fullname: Frank, Derk
  organization: Department of Internal Medicine III (Cardiology, Angiology and Intensive Care Medicine), German Centre for Cardiovascular Research, partner site Hamburg/Kiel/Lübeck, Arnold-Heller Strasse 3, Haus K3, Kiel 24105, Germany
– sequence: 2
  givenname: Eric
  orcidid: 0000-0001-8171-7959
  surname: Durand
  fullname: Durand, Eric
  organization: Department of Cardiology, Univ Rouen Normandie, Inserm U1096, CHU Rouen, Rouen, France
– sequence: 3
  givenname: Sandra
  orcidid: 0000-0002-0181-559X
  surname: Lauck
  fullname: Lauck, Sandra
  organization: Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, BC, Canada
– sequence: 4
  givenname: Douglas F
  orcidid: 0000-0003-1871-2869
  surname: Muir
  fullname: Muir, Douglas F
  organization: Cardiology Department, James Cook University Hospital, Middlesbrough, UK
– sequence: 5
  givenname: Mark
  surname: Spence
  fullname: Spence, Mark
  organization: Cardiology Department, Mater Private Network, Dublin, Ireland
– sequence: 6
  givenname: Mariuca
  surname: Vasa-Nicotera
  fullname: Vasa-Nicotera, Mariuca
  organization: Cardiology Department, Hospital Sindelfingen-Böblingen, Sindelfingen, Germany
– sequence: 7
  givenname: David
  surname: Wood
  fullname: Wood, David
  organization: Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, BC, Canada
– sequence: 8
  givenname: Francesco
  orcidid: 0000-0001-9969-2649
  surname: Saia
  fullname: Saia, Francesco
  organization: Department of Cardiology, University of Bologna, Policlinico S. Orsola-Malpighi, Bologna, Italy
– sequence: 9
  givenname: Cristóbal A
  orcidid: 0000-0002-9504-8861
  surname: Urbano-Carrillo
  fullname: Urbano-Carrillo, Cristóbal A
  organization: Cardiology Department, Hospital Regional Universitario de Málaga, Malaga, Spain
– sequence: 10
  givenname: Damien
  surname: Bouchayer
  fullname: Bouchayer, Damien
  organization: Department of Cardiology, The Clinique de l'Infirmerie Protestante, Lyon, France
– sequence: 11
  givenname: Vlad Anton
  orcidid: 0000-0002-7290-3300
  surname: Iliescu
  fullname: Iliescu, Vlad Anton
  organization: Department of Cardiology, University of Medicine and Pharmacy Carol Davila, Bucharest, Romania
– sequence: 12
  givenname: Christophe
  surname: Saint Etienne
  fullname: Saint Etienne, Christophe
  organization: Department of Cardiology, Centre Hospitalier Régional Universitaire (CHRU) de Tours, Hôpital Trousseau, Tours, France
– sequence: 13
  givenname: Florence
  orcidid: 0000-0001-5936-5184
  surname: Leclercq
  fullname: Leclercq, Florence
  organization: Cardiology Department, Montpellier University Hospital, Montpellier University, Montpellier, France
– sequence: 14
  givenname: Vincent
  orcidid: 0000-0002-9481-646X
  surname: Auffret
  fullname: Auffret, Vincent
  organization: Université de Rennes 1, CHU Rennes Service de Cardiologie, Inserm LTSI U1099, Rennes, France
– sequence: 15
  givenname: Lluis
  orcidid: 0000-0002-3357-5834
  surname: Asmarats
  fullname: Asmarats, Lluis
  organization: Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain
– sequence: 16
  givenname: Carlo
  orcidid: 0000-0002-4461-2055
  surname: Di Mario
  fullname: Di Mario, Carlo
  organization: Structural Interventional Cardiology Division, Department of Clinical & Experimental Medicine, Careggi University Hospital, Florence, Italy
– sequence: 17
  givenname: Aurelie
  surname: Veugeois
  fullname: Veugeois, Aurelie
  organization: Department of Cardiology, Institut Mutualiste Montsouris, Paris, France
– sequence: 18
  givenname: Jiri
  orcidid: 0000-0002-7863-245X
  surname: Maly
  fullname: Maly, Jiri
  organization: Cardiac Center, IKEM Prague, Prague, Czech Republic
– sequence: 19
  givenname: Andreas
  orcidid: 0000-0003-1410-6108
  surname: Schober
  fullname: Schober, Andreas
  organization: Karl Landsteiner Institute for Cardiovascular and Critical Care Research Vienna, Vienna, Austria
– sequence: 20
  givenname: Luis
  orcidid: 0000-0003-3438-8907
  surname: Nombela-Franco
  fullname: Nombela-Franco, Luis
  organization: Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
– sequence: 21
  givenname: Nikos
  surname: Werner
  fullname: Werner, Nikos
  organization: Medical Department III, Heart Center Trier, Krankenhaus der Barmherzigen Brüder, Trier, Germany
– sequence: 22
  givenname: Joan Antoni
  orcidid: 0000-0002-3249-3095
  surname: Gómez-Hospital
  fullname: Gómez-Hospital, Joan Antoni
  organization: Heart Diseases Institute, Bellvitge University Hospital-IDIBELL, University of Barcelona, Barcelona, Spain
– sequence: 23
  givenname: Julia
  orcidid: 0000-0001-7478-1450
  surname: Mascherbauer
  fullname: Mascherbauer, Julia
  organization: Department of Internal Medicine 3/Cardiology, University Hospital St. Pölten, St. Pölten, Austria
– sequence: 24
  givenname: Giuseppe
  orcidid: 0000-0001-6016-5702
  surname: Musumeci
  fullname: Musumeci, Giuseppe
  organization: Struttura Complessa of Cardiology, Ospedale Mauriziano, Torino, Italy
– sequence: 25
  givenname: Nicolas
  orcidid: 0000-0002-1017-0463
  surname: Meneveau
  fullname: Meneveau, Nicolas
  organization: Cardiology, Besancon Regional University Hospital Center, Besancon, France
– sequence: 26
  givenname: Thibaud
  surname: Meurice
  fullname: Meurice, Thibaud
  organization: Cardiology, Polyclinique Du Bois, Lille, France
– sequence: 27
  givenname: Felix
  orcidid: 0000-0002-4425-549X
  surname: Mahfoud
  fullname: Mahfoud, Felix
  organization: Internal Medicine III, Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital of Saarland, Homburg, Germany
– sequence: 28
  givenname: Federico
  orcidid: 0000-0003-3554-6938
  surname: De Marco
  fullname: De Marco, Federico
  organization: Cardiology, Centro Cardiologico Monzino, Milan, Italy
– sequence: 29
  givenname: Tim
  orcidid: 0000-0002-6158-5087
  surname: Seidler
  fullname: Seidler, Tim
  organization: Department of Cardiology, Kerckhoff-Klinik, Bad Nauheim, Germany
– sequence: 30
  givenname: Florian
  orcidid: 0000-0003-1157-474X
  surname: Leuschner
  fullname: Leuschner, Florian
  organization: Department of Medicine III, University of Heidelberg, German Centre for Cardiovascular Research (DZHK), Heilderberg, Germany
– sequence: 31
  givenname: Patrick
  surname: Joly
  fullname: Joly, Patrick
  organization: Department of Interventional Cardiology, Hôpital Saint Joseph, Marseille, France
– sequence: 32
  givenname: Jean-Philippe
  orcidid: 0000-0003-3750-5347
  surname: Collet
  fullname: Collet, Jean-Philippe
  organization: Department de Cardiologie, Hôpital de Pitié-Salpêtrière AP-HP, Paris, France
– sequence: 33
  givenname: Ferdinand
  orcidid: 0000-0002-1924-6823
  surname: Vogt
  fullname: Vogt, Ferdinand
  organization: Department for Cardiovascular Surgery, Artemed Klinikum München, München, Germany
– sequence: 34
  givenname: Emilio
  surname: Di Lorenzo
  fullname: Di Lorenzo, Emilio
  organization: Division of Cardiology, Department of Cardiovascular Surgery, L'Ospedale S.Giuseppe Moscati di Avellino, Avellino, Italy
– sequence: 35
  givenname: Elmar
  orcidid: 0000-0001-6301-7422
  surname: Kuhn
  fullname: Kuhn, Elmar
  organization: Department of Cardiothoracic Surgery, Heart Center, Faculty of Medicine, University Hospital of Cologne, Cologne, Germany
– sequence: 36
  givenname: Vicente Peral
  orcidid: 0000-0003-0379-5243
  surname: Disdier
  fullname: Disdier, Vicente Peral
  organization: Cardiology Department, University Hospital Son Espases, Palma de Mallorca, Spain
– sequence: 37
  givenname: Violetta
  orcidid: 0000-0002-0279-3476
  surname: Hachaturyan
  fullname: Hachaturyan, Violetta
  organization: Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
– sequence: 38
  givenname: Claudia M
  orcidid: 0000-0001-7084-0628
  surname: Lüske
  fullname: Lüske, Claudia M
  organization: Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
– sequence: 39
  givenname: Radka
  orcidid: 0009-0000-5151-7542
  surname: Rakova
  fullname: Rakova, Radka
  organization: Edwards Lifesciences, Prague, Czech Republic
– sequence: 40
  givenname: Wilbert
  orcidid: 0000-0001-6494-2919
  surname: Wesselink
  fullname: Wesselink, Wilbert
  organization: Edwards Lifesciences, Prague, Czech Republic
– sequence: 41
  givenname: Jana
  orcidid: 0009-0003-4704-0499
  surname: Kurucova
  fullname: Kurucova, Jana
  organization: Edwards Lifesciences, Prague, Czech Republic
– sequence: 42
  givenname: Peter
  orcidid: 0000-0003-4970-2110
  surname: Bramlage
  fullname: Bramlage, Peter
  organization: Institute for Pharmacology and Preventive Medicine, Cloppenburg, Germany
– sequence: 43
  givenname: Gemma
  orcidid: 0000-0001-6322-072X
  surname: McCalmont
  fullname: McCalmont, Gemma
  organization: Edwards Lifesciences, Nyon, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38554125$$D View this record in MEDLINE/PubMed
https://hal.science/hal-04534032$$DView record in HAL
BookMark eNpdkV9v0zAUxS00xLrBB-AF-REesvl_Yl5QqQZFFJAQIN4sx7khmZK4s52ifns8tauAJ0vH5_x8r88FOpv8BAg9p-SKEs2vYQ4d2JBur6GzQEX5CC2oZKzQSsgztCBUy0Kp6uc5uojxlhBSKaqeoHNeSSkokwv0Y4ljCmDHoZ-gwVubut92j1sfcAp2ii4LkCBg60PqHd7ZYQe4H7eDnZJNvZ9e4-zAb28-r9afll8_Ztzc7J-ix60dIjw7npfo-7ubb6t1sfny_sNquSkcVyIVVVlr0ShZMsE4SC1BaG01cNZWAohUZc1drSVRrgEnuGtda2tLibJ5tSxcojcH7nauR2gcTHnqwWxDP9qwN9725t-bqe_ML78zlFLBeVVmwqsDofsvt15uzL1GhOSCcLaj2fvy-FrwdzPEZMY-OhjyX4Cfo-GEMVnSUqpspQerCz7GAO2JTYm5L8-cyjPH8nLmxd_LnBIPbfE_Ybqb1Q
CitedBy_id crossref_primary_10_1016_j_jcin_2024_04_018
Cites_doi 10.1002/ccd.27230
10.1016/j.amjcard.2016.06.035
10.2217/fca-2020-0010
10.1016/j.amjcard.2020.12.086
10.1016/j.jcin.2023.07.005
10.1002/clc.23711
10.1016/j.ijcard.2022.01.038
10.5603/CJ.a2017.0087
10.1016/j.amjcard.2015.01.546
10.1016/j.cjco.2021.04.006
10.4244/EIJV11I2A41
10.3390/jcm11051205
10.1016/j.carrev.2020.12.002
10.1016/j.jcin.2022.03.022
10.1136/heartjnl-2014-307351
10.1016/j.jcin.2018.12.020
10.1007/s12471-020-01374-5
10.1186/s12872-017-0693-0
10.1093/eurheartj/ehae081
10.1016/j.jacc.2021.02.038
10.1161/CIRCOUTCOMES.115.002541
10.1016/0022-3956(75)90026-6
10.1177/1474515120934057
10.1002/ehf2.12961
10.1161/JAHA.119.013160
10.1016/j.jcin.2017.10.021
10.4244/EIJ-D-18-01197
10.1001/jama.1963.03060120024016
10.1016/j.amjcard.2023.07.072
10.1111/joic.12373
10.1001/jamacardio.2016.5302
10.1161/CIRCINTERVENTIONS.122.012168
10.1016/j.carrev.2020.05.044
10.1002/ccd.28617
ContentType Journal Article
Contributor Berger, Ann-Kathrin
Waschbüsch, Hannah
Koch, Christina
Daunert, Jaume Maristany
Butkovic, Mirela
Muir, Douglas
Rakova, Radka
Saia, Francesco
Lauterbach, Michael
Hünermund, Maren
Pozzi, María Aránzazu Ortega
Ewen, Sebastian
Perrero, Martina
Parasca, Catalina Andreea
Leuschner, Florian
Nombela-Franco, Luis
Maly, Jiri
Delle-Karth, Georg
de la Bandera Sanchez, Maria Carmen
Lüske, Claudia M
De Marco, Federico
Seidler, Tim
Frank, Derk
Perrier, Hervé
Gal, Rosalie Le
Meucci, Francesco
Muntané, Guillem
Asmarats, Lluis
McCalmont, Gemma
Müller, Carolin
Ulbricht, Hannah
Lassouani, Katia
Zitouni, Wassim
Urbano-Carrillo, Cristóbal A
Cefalo, Barbara
Kurucova, Jana
Frebault, Viktoria
Musumeci, Giuseppe
Leitgeb, Marie-Christine
Popescu, Simona
Engel, Alexandra
Antoni, Joan
Wood, David
Siame, Sabrina
Etienne, Christophe Saint
Disdier, Vicente Peral
Watbled, Stephanie
Scheller, Bruno
Bagdadi, Imane
Claudel, Jean-Philippe
Iliescu, Vlad Anton
Veugeois, Aurelie
Spence, Mark
Olivares, Paolo
Xarrie, Elena Jimenez
Schuster, Claudia
Meurice, Thibaud
Lauck, Sandra
Wolf
Contributor_xml – sequence: 1
  givenname: Derk
  surname: Frank
  fullname: Frank, Derk
– sequence: 2
  givenname: Gemma
  surname: McCalmont
  fullname: McCalmont, Gemma
– sequence: 3
  givenname: Peter
  surname: Bramlage
  fullname: Bramlage, Peter
– sequence: 4
  givenname: Claudia M
  surname: Lüske
  fullname: Lüske, Claudia M
– sequence: 5
  givenname: Marie
  surname: Zielinski
  fullname: Zielinski, Marie
– sequence: 6
  givenname: Daniel
  surname: Greinert
  fullname: Greinert, Daniel
– sequence: 7
  givenname: Cornelia
  surname: Deutsch
  fullname: Deutsch, Cornelia
– sequence: 8
  givenname: Violetta
  surname: Hachaturyan
  fullname: Hachaturyan, Violetta
– sequence: 9
  givenname: Eric
  surname: Durand
  fullname: Durand, Eric
– sequence: 10
  givenname: Sandra
  surname: Lauck
  fullname: Lauck, Sandra
– sequence: 11
  givenname: Douglas
  surname: Muir
  fullname: Muir, Douglas
– sequence: 12
  givenname: Mark
  surname: Spence
  fullname: Spence, Mark
– sequence: 13
  givenname: Mariuca
  surname: Vasa-Nicotera
  fullname: Vasa-Nicotera, Mariuca
– sequence: 14
  givenname: David
  surname: Wood
  fullname: Wood, David
– sequence: 15
  givenname: Francesco
  surname: Saia
  fullname: Saia, Francesco
– sequence: 16
  givenname: Jana
  surname: Kurucova
  fullname: Kurucova, Jana
– sequence: 17
  givenname: Wilbert
  surname: Wesselink
  fullname: Wesselink, Wilbert
– sequence: 18
  givenname: Radka
  surname: Rakova
  fullname: Rakova, Radka
– sequence: 19
  givenname: Martin
  surname: Thoenes
  fullname: Thoenes, Martin
– sequence: 20
  givenname: Cristóbal A
  surname: Urbano-Carrillo
  fullname: Urbano-Carrillo, Cristóbal A
– sequence: 21
  givenname: Carlos Lara
  surname: García
  fullname: García, Carlos Lara
– sequence: 22
  givenname: Beatriz
  surname: Chamorro
  fullname: Chamorro, Beatriz
– sequence: 23
  givenname: Damien
  surname: Bouchayer
  fullname: Bouchayer, Damien
– sequence: 24
  givenname: Jean-Philippe
  surname: Claudel
  fullname: Claudel, Jean-Philippe
– sequence: 25
  givenname: Hervé
  surname: Perrier
  fullname: Perrier, Hervé
– sequence: 26
  givenname: Viktoria
  surname: Frebault
  fullname: Frebault, Viktoria
– sequence: 27
  givenname: Vlad Anton
  surname: Iliescu
  fullname: Iliescu, Vlad Anton
– sequence: 28
  givenname: Catalina Andreea
  surname: Parasca
  fullname: Parasca, Catalina Andreea
– sequence: 29
  givenname: Christophe Saint
  surname: Etienne
  fullname: Etienne, Christophe Saint
– sequence: 30
  givenname: Katia
  surname: Lassouani
  fullname: Lassouani, Katia
– sequence: 31
  givenname: Florence
  surname: Leclercq
  fullname: Leclercq, Florence
– sequence: 32
  givenname: Wassim
  surname: Zitouni
  fullname: Zitouni, Wassim
– sequence: 33
  givenname: Sonia
  surname: Soltani
  fullname: Soltani, Sonia
– sequence: 34
  givenname: Vincent
  surname: Auffret
  fullname: Auffret, Vincent
– sequence: 35
  givenname: Rosalie Le
  surname: Gal
  fullname: Gal, Rosalie Le
– sequence: 36
  givenname: Lluis
  surname: Asmarats
  fullname: Asmarats, Lluis
– sequence: 37
  givenname: Elena Jimenez
  surname: Xarrie
  fullname: Xarrie, Elena Jimenez
– sequence: 38
  givenname: Carlo
  surname: Di Mario
  fullname: Di Mario, Carlo
– sequence: 39
  givenname: Niccolo
  surname: Ciardetti
  fullname: Ciardetti, Niccolo
– sequence: 40
  givenname: Francesco
  surname: Meucci
  fullname: Meucci, Francesco
– sequence: 41
  givenname: Aurelie
  surname: Veugeois
  fullname: Veugeois, Aurelie
– sequence: 42
  givenname: Imane
  surname: Bagdadi
  fullname: Bagdadi, Imane
– sequence: 43
  givenname: Jiri
  surname: Maly
  fullname: Maly, Jiri
– sequence: 44
  givenname: Lenka
  surname: Kolinova
  fullname: Kolinova, Lenka
– sequence: 45
  givenname: Andreas
  surname: Schober
  fullname: Schober, Andreas
– sequence: 46
  givenname: Georg
  surname: Delle-Karth
  fullname: Delle-Karth, Georg
– sequence: 47
  givenname: Claudia
  surname: Schuster
  fullname: Schuster, Claudia
– sequence: 48
  givenname: Marie-Christine
  surname: Leitgeb
  fullname: Leitgeb, Marie-Christine
– sequence: 49
  givenname: Luis
  surname: Nombela-Franco
  fullname: Nombela-Franco, Luis
– sequence: 50
  givenname: Esther Bernardo
  surname: García
  fullname: García, Esther Bernardo
– sequence: 51
  givenname: María Aránzazu Ortega
  surname: Pozzi
  fullname: Pozzi, María Aránzazu Ortega
– sequence: 52
  givenname: Nikos
  surname: Werner
  fullname: Werner, Nikos
– sequence: 53
  givenname: Jürgen
  surname: Leick
  fullname: Leick, Jürgen
– sequence: 54
  givenname: Michael
  surname: Lauterbach
  fullname: Lauterbach, Michael
– sequence: 55
  givenname: Hannah
  surname: Waschbüsch
  fullname: Waschbüsch, Hannah
– sequence: 56
  givenname: Joan
  surname: Antoni
  fullname: Antoni, Joan
– sequence: 57
  givenname: Guillem
  surname: Muntané
  fullname: Muntané, Guillem
– sequence: 58
  givenname: Julia Mascherbauer Olga
  surname: Daxböck
  fullname: Daxböck, Julia Mascherbauer Olga
– sequence: 59
  givenname: Mirela
  surname: Butkovic
  fullname: Butkovic, Mirela
– sequence: 60
  givenname: Simona
  surname: Popescu
  fullname: Popescu, Simona
– sequence: 61
  givenname: Giuseppe
  surname: Musumeci
  fullname: Musumeci, Giuseppe
– sequence: 62
  givenname: Martina
  surname: Perrero
  fullname: Perrero, Martina
– sequence: 63
  givenname: Nicolas
  surname: Meneveau
  fullname: Meneveau, Nicolas
– sequence: 64
  givenname: Stephanie
  surname: Watbled
  fullname: Watbled, Stephanie
– sequence: 65
  givenname: Thibaud
  surname: Meurice
  fullname: Meurice, Thibaud
– sequence: 66
  givenname: Maxence
  surname: Delomez
  fullname: Delomez, Maxence
– sequence: 67
  givenname: Felix
  surname: Mahfoud
  fullname: Mahfoud, Felix
– sequence: 68
  givenname: Bruno
  surname: Scheller
  fullname: Scheller, Bruno
– sequence: 69
  givenname: Sebastian
  surname: Ewen
  fullname: Ewen, Sebastian
– sequence: 70
  givenname: Ann-Kathrin
  surname: Berger
  fullname: Berger, Ann-Kathrin
– sequence: 71
  givenname: Christina
  surname: Koch
  fullname: Koch, Christina
– sequence: 72
  givenname: Alexandra
  surname: Engel
  fullname: Engel, Alexandra
– sequence: 73
  givenname: Federico
  surname: De Marco
  fullname: De Marco, Federico
– sequence: 74
  givenname: Paolo
  surname: Olivares
  fullname: Olivares, Paolo
– sequence: 75
  givenname: Tim
  surname: Seidler
  fullname: Seidler, Tim
– sequence: 76
  givenname: Frieder
  surname: Wolf
  fullname: Wolf, Frieder
– sequence: 77
  givenname: Carolin
  surname: Müller
  fullname: Müller, Carolin
– sequence: 78
  givenname: Maren
  surname: Hünermund
  fullname: Hünermund, Maren
– sequence: 79
  givenname: Florian
  surname: Leuschner
  fullname: Leuschner, Florian
– sequence: 80
  givenname: Mathias
  surname: Konstandin
  fullname: Konstandin, Mathias
– sequence: 81
  givenname: Lisa
  surname: Linz
  fullname: Linz, Lisa
– sequence: 82
  givenname: Hannah
  surname: Ulbricht
  fullname: Ulbricht, Hannah
– sequence: 83
  givenname: Patrick
  surname: Joly
  fullname: Joly, Patrick
– sequence: 84
  givenname: Sabrina
  surname: Siame
  fullname: Siame, Sabrina
– sequence: 85
  givenname: Jean-Philippe
  surname: Collet
  fullname: Collet, Jean-Philippe
– sequence: 86
  givenname: Nassima Ait
  surname: Amrane
  fullname: Amrane, Nassima Ait
– sequence: 87
  givenname: Ferdinand
  surname: Vogt
  fullname: Vogt, Ferdinand
– sequence: 88
  givenname: Dow
  surname: Rosenzweig
  fullname: Rosenzweig, Dow
– sequence: 89
  givenname: Emilio
  surname: Di Lorenzo
  fullname: Di Lorenzo, Emilio
– sequence: 90
  givenname: Barbara
  surname: Cefalo
  fullname: Cefalo, Barbara
– sequence: 91
  givenname: Elmar
  surname: Kuhn
  fullname: Kuhn, Elmar
– sequence: 92
  givenname: Vera
  surname: Wolf
  fullname: Wolf, Vera
– sequence: 93
  givenname: Vicente Peral
  surname: Disdier
  fullname: Disdier, Vicente Peral
– sequence: 94
  givenname: Jaume Maristany
  surname: Daunert
  fullname: Daunert, Jaume Maristany
– sequence: 95
  givenname: Maria Carmen
  surname: de la Bandera Sanchez
  fullname: de la Bandera Sanchez, Maria Carmen
Copyright The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Attribution
The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024
Copyright_xml – notice: The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
– notice: Attribution
– notice: The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. 2024
CorporateAuthor BENCHMARK Investigator Group
for the BENCHMARK Investigator Group
CorporateAuthor_xml – name: BENCHMARK Investigator Group
– name: for the BENCHMARK Investigator Group
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
1XC
VOOES
5PM
DOI 10.1093/eurheartj/ehae147
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Hyper Article en Ligne (HAL)
Hyper Article en Ligne (HAL) (Open Access)
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-9645
EndPage 1916
ExternalDocumentID oai_HAL_hal_04534032v1
10_1093_eurheartj_ehae147
38554125
Genre Multicenter Study
Journal Article
GeographicLocations Europe
GeographicLocations_xml – name: Europe
GrantInformation_xml – fundername: Institute for Pharmacology and Preventive Medicine GmbH
– fundername: Edwards Lifesciences and performed under the sponsorship of IPPMed
– fundername: ;
GroupedDBID ---
-E4
.2P
.I3
.XZ
.ZR
08P
0R~
18M
1TH
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
70D
AABZA
AACZT
AAJKP
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AASNB
AAUAY
AAVAP
ABEUO
ABIXL
ABKDP
ABNHQ
ABNKS
ABOCM
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCGUY
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DILTD
D~K
E3Z
EBS
ECM
EE~
EIF
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
H5~
HAR
HW0
HZ~
IOX
J21
KAQDR
KOP
KQ8
KSI
KSN
L7B
M-Z
M41
M49
MHKGH
N9A
NGC
NOMLY
NOYVH
NPM
NU-
O9-
OAUYM
OAWHX
OB3
OCZFY
ODMLO
OGROG
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
ROL
ROX
RUSNO
RW1
RXO
SEL
TCURE
TEORI
TJX
WOQ
X7H
YAYTL
YKOAZ
YXANX
ZKX
~91
AAYXX
CITATION
7X8
ABSAR
1XC
VOOES
5PM
ID FETCH-LOGICAL-c364t-87b94d6572423e595e499a9e32f84e0567b3cb9506cdec43cfcfaba106a195c43
ISSN 0195-668X
1522-9645
IngestDate Tue Sep 17 21:28:27 EDT 2024
Thu Sep 12 06:30:50 EDT 2024
Sat Aug 17 04:22:31 EDT 2024
Thu Sep 26 16:39:13 EDT 2024
Wed Oct 09 10:32:00 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 21
Keywords Aortic stenosis
Transcatheter aortic valve implantation
Prospective registry
Health services
TAVI
Clinical care
Quality of care
Language English
License The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.
Attribution: http://creativecommons.org/licenses/by
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c364t-87b94d6572423e595e499a9e32f84e0567b3cb9506cdec43cfcfaba106a195c43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Deceased on December 15th, 2023
ORCID 0000-0002-1017-0463
0000-0002-6158-5087
0000-0003-1157-474X
0000-0003-1410-6108
0000-0001-8171-7959
0000-0002-7290-3300
0009-0000-5151-7542
0000-0002-0279-3476
0000-0002-9481-646X
0000-0001-6494-2919
0000-0001-7478-1450
0000-0002-4425-549X
0000-0003-3438-8907
0000-0001-6016-5702
0000-0003-3750-5347
0000-0002-3249-3095
0000-0003-0379-5243
0000-0003-1871-2869
0000-0001-6301-7422
0000-0002-0181-559X
0009-0003-4704-0499
0000-0003-4970-2110
0000-0002-3357-5834
0000-0001-9969-2649
0000-0001-5936-5184
0000-0001-7084-0628
0000-0001-7561-075X
0000-0002-4461-2055
0000-0002-7863-245X
0000-0002-9504-8861
0000-0002-1924-6823
0000-0003-3554-6938
0000-0001-6322-072X
0000-0002-7826-7237
0000-0003-0535-2120
0000-0002-8260-8890
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11143387
PMID 38554125
PQID 3022571756
PQPubID 23479
PageCount 13
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11143387
hal_primary_oai_HAL_hal_04534032v1
proquest_miscellaneous_3022571756
crossref_primary_10_1093_eurheartj_ehae147
pubmed_primary_38554125
PublicationCentury 2000
PublicationDate 2024-Jun-01
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-Jun-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: UK
PublicationTitle European heart journal
PublicationTitleAlternate Eur Heart J
PublicationYear 2024
Publisher Oxford University Press (OUP)
Oxford University Press
Publisher_xml – name: Oxford University Press (OUP)
– name: Oxford University Press
References Durand (2024060106515155800_ehae147-B8) 2015; 115
Généreux (2024060106515155800_ehae147-B29) 2021; 77
Lauck (2024060106515155800_ehae147-B30) 2020; 21
Krishnaswamy (2024060106515155800_ehae147-B34) 2022; 15
Butala (2024060106515155800_ehae147-B12) 2022; 15
Bona (2024060106515155800_ehae147-B32) 2015; 11
Lauck (2024060106515155800_ehae147-B33) 2021; 3
Vendrik (2024060106515155800_ehae147-B1) 2020; 28
Bohmann (2024060106515155800_ehae147-B16) 2022; 11
Frank (2024060106515155800_ehae147-B20) 2021; 8
Joseph (2024060106515155800_ehae147-B27) 2021; 31
McCalmont (2024060106515155800_ehae147-B17) 2021; 44
Katz (2024060106515155800_ehae147-B18) 1963; 185
Barbanti (2024060106515155800_ehae147-B3) 2015; 101
Barbanti (2024060106515155800_ehae147-B13) 2019; 15
Arnold (2024060106515155800_ehae147-B31) 2017; 2
Lauck (2024060106515155800_ehae147-B2) 2016; 9
Barbanti (2024060106515155800_ehae147-B14) 2017; 17
Lortz (2024060106515155800_ehae147-B21) 2021; 17
Folstein (2024060106515155800_ehae147-B19) 1975; 12
Aldalati (2024060106515155800_ehae147-B4) 2018; 25
Alkhalil (2024060106515155800_ehae147-B5) 2018; 91
Steeds (2024060106515155800_ehae147-B35) 2019; 8
Lauck (2024060106515155800_ehae147-B11) 2020; 96
Reddavid (2024060106515155800_ehae147-B23) 2022; 352
Ryffel (2024060106515155800_ehae147-B26) 2023; 204
Mallikethi-Reddy (2024060106515155800_ehae147-B6) 2017; 30
Durand (2024060106515155800_ehae147-B22) 2024; 45
Serletis-Bizios (2024060106515155800_ehae147-B9) 2016; 118
Valdebenito (2024060106515155800_ehae147-B24) 2021; 145
Wood (2024060106515155800_ehae147-B10) 2019; 12
Lauck (2024060106515155800_ehae147-B15) 2020; 19
Kamioka (2024060106515155800_ehae147-B7) 2018; 11
Tan (2024060106515155800_ehae147-B25) 2021; 107
Avvedimento (2024060106515155800_ehae147-B28) 2023; 16
References_xml – volume: 91
  start-page: 345
  year: 2018
  ident: 2024060106515155800_ehae147-B5
  article-title: Safety of shorter length of hospital stay for patients undergoing minimalist transcatheter aortic valve replacement
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.27230
  contributor:
    fullname: Alkhalil
– volume: 118
  start-page: 866
  year: 2016
  ident: 2024060106515155800_ehae147-B9
  article-title: A prospective analysis of early discharge after transfemoral transcatheter aortic valve implantation
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2016.06.035
  contributor:
    fullname: Serletis-Bizios
– volume: 17
  start-page: 321
  year: 2021
  ident: 2024060106515155800_ehae147-B21
  article-title: Clinical process optimization of transfemoral transcatheter aortic valve implantation
  publication-title: Future Cardiol
  doi: 10.2217/fca-2020-0010
  contributor:
    fullname: Lortz
– volume: 145
  start-page: 97
  year: 2021
  ident: 2024060106515155800_ehae147-B24
  article-title: Transcatheter aortic valve implantation during the COVID-19 pandemic
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2020.12.086
  contributor:
    fullname: Valdebenito
– volume: 16
  start-page: 2262
  year: 2023
  ident: 2024060106515155800_ehae147-B28
  article-title: Incidence, predictors, and prognostic impact of bleeding events after TAVR according to VARC-3 criteria
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2023.07.005
  contributor:
    fullname: Avvedimento
– volume: 44
  start-page: 1344
  year: 2021
  ident: 2024060106515155800_ehae147-B17
  article-title: Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe-rationale and design of the international BENCHMARK registry
  publication-title: Clin Cardiol
  doi: 10.1002/clc.23711
  contributor:
    fullname: McCalmont
– volume: 352
  start-page: 190
  year: 2022
  ident: 2024060106515155800_ehae147-B23
  article-title: Transcatheter aortic valve implantation during COVID-19 pandemic: an optimized model to relieve healthcare system overload
  publication-title: Int J Cardiol
  doi: 10.1016/j.ijcard.2022.01.038
  contributor:
    fullname: Reddavid
– volume: 25
  start-page: 14
  year: 2018
  ident: 2024060106515155800_ehae147-B4
  article-title: Factors associated with safe early discharge after transcatheter aortic valve implantation
  publication-title: Cardiol J
  doi: 10.5603/CJ.a2017.0087
  contributor:
    fullname: Aldalati
– volume: 115
  start-page: 1116
  year: 2015
  ident: 2024060106515155800_ehae147-B8
  article-title: Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation with the Edwards SAPIEN-XT prosthesis
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2015.01.546
  contributor:
    fullname: Durand
– volume: 3
  start-page: 1033
  year: 2021
  ident: 2024060106515155800_ehae147-B33
  article-title: Quality-of-life outcomes after transcatheter aortic valve implantation in a “real world” population: insights from a prospective Canadian database
  publication-title: CJC Open
  doi: 10.1016/j.cjco.2021.04.006
  contributor:
    fullname: Lauck
– volume: 11
  start-page: 221
  year: 2015
  ident: 2024060106515155800_ehae147-B32
  article-title: Early and late changes in quality of life following transcatheter aortic valve implantation using the transfemoral and transapical approaches
  publication-title: EuroIntervention
  doi: 10.4244/EIJV11I2A41
  contributor:
    fullname: Bona
– volume: 11
  start-page: 1205
  year: 2022
  ident: 2024060106515155800_ehae147-B16
  article-title: The COORDINATE pilot study: impact of a transcatheter aortic valve coordinator program on hospital and patient outcomes
  publication-title: J Clin Med
  doi: 10.3390/jcm11051205
  contributor:
    fullname: Bohmann
– volume: 31
  start-page: 26
  year: 2021
  ident: 2024060106515155800_ehae147-B27
  article-title: Safety and operational efficiency of restructuring and redeploying a transcatheter aortic valve replacement service during the COVID-19 pandemic: the Oxford experience
  publication-title: Cardiovasc Revasc Med
  doi: 10.1016/j.carrev.2020.12.002
  contributor:
    fullname: Joseph
– volume: 15
  start-page: 1288
  year: 2022
  ident: 2024060106515155800_ehae147-B34
  article-title: Minimalist mitral valve-in-valve replacement using conscious sedation and intracardiac echocardiography is feasible and safe
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2022.03.022
  contributor:
    fullname: Krishnaswamy
– volume: 101
  start-page: 1485
  year: 2015
  ident: 2024060106515155800_ehae147-B3
  article-title: Early discharge after transfemoral transcatheter aortic valve implantation
  publication-title: Heart
  doi: 10.1136/heartjnl-2014-307351
  contributor:
    fullname: Barbanti
– volume: 12
  start-page: 459
  year: 2019
  ident: 2024060106515155800_ehae147-B10
  article-title: The Vancouver 3 M (multidisciplinary, multimodality, but minimalist) clinical pathway facilitates safe next-day discharge home at low-, medium-, and high-volume transfemoral transcatheter aortic valve replacement centers: the 3 M TAVR study
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2018.12.020
  contributor:
    fullname: Wood
– volume: 28
  start-page: 240
  year: 2020
  ident: 2024060106515155800_ehae147-B1
  article-title: Early mobilisation after transfemoral transcatheter aortic valve implantation: results of the MobiTAVI trial
  publication-title: Neth Heart J
  doi: 10.1007/s12471-020-01374-5
  contributor:
    fullname: Vendrik
– volume: 17
  start-page: 259
  year: 2017
  ident: 2024060106515155800_ehae147-B14
  article-title: Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation—rationale and design of the FAST-TAVI registry
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/s12872-017-0693-0
  contributor:
    fullname: Barbanti
– volume: 45
  start-page: 952
  year: 2024
  ident: 2024060106515155800_ehae147-B22
  article-title: Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehae081
  contributor:
    fullname: Durand
– volume: 77
  start-page: 2717
  year: 2021
  ident: 2024060106515155800_ehae147-B29
  article-title: Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2021.02.038
  contributor:
    fullname: Généreux
– volume: 9
  start-page: 312
  year: 2016
  ident: 2024060106515155800_ehae147-B2
  article-title: Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay
  publication-title: Circ Cardiovasc Qual Outcomes
  doi: 10.1161/CIRCOUTCOMES.115.002541
  contributor:
    fullname: Lauck
– volume: 12
  start-page: 189
  year: 1975
  ident: 2024060106515155800_ehae147-B19
  article-title: Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
  publication-title: J Psychiatr Res
  doi: 10.1016/0022-3956(75)90026-6
  contributor:
    fullname: Folstein
– volume: 19
  start-page: 537
  year: 2020
  ident: 2024060106515155800_ehae147-B15
  article-title: Facilitating transcatheter aortic valve implantation in the era of COVID-19: recommendations for programmes
  publication-title: Eur J Cardiovasc Nurs
  doi: 10.1177/1474515120934057
  contributor:
    fullname: Lauck
– volume: 8
  start-page: 270
  year: 2021
  ident: 2024060106515155800_ehae147-B20
  article-title: Aortic valve replacement: validation of the Toronto Aortic Stenosis Quality of Life Questionnaire
  publication-title: ESC Heart Fail
  doi: 10.1002/ehf2.12961
  contributor:
    fullname: Frank
– volume: 8
  start-page: e013160
  year: 2019
  ident: 2024060106515155800_ehae147-B35
  article-title: Facilitated data relay and effects on treatment of severe aortic stenosis in Europe
  publication-title: J Am Heart Assoc
  doi: 10.1161/JAHA.119.013160
  contributor:
    fullname: Steeds
– volume: 11
  start-page: 107
  year: 2018
  ident: 2024060106515155800_ehae147-B7
  article-title: Predictors and clinical outcomes of next-day discharge after minimalist transfemoral transcatheter aortic valve replacement
  publication-title: JACC Cardiovasc Interv
  doi: 10.1016/j.jcin.2017.10.021
  contributor:
    fullname: Kamioka
– volume: 15
  start-page: 147
  year: 2019
  ident: 2024060106515155800_ehae147-B13
  article-title: Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trial
  publication-title: EuroIntervention
  doi: 10.4244/EIJ-D-18-01197
  contributor:
    fullname: Barbanti
– volume: 107
  start-page: A13
  year: 2021
  ident: 2024060106515155800_ehae147-B25
  article-title: 17 the impact of the COVID-19 pandemic on transcatheter aortic valve implantation (TAVI) services in the United Kingdom: a tertiary centre experience
  publication-title: Heart
  contributor:
    fullname: Tan
– volume: 185
  start-page: 914
  year: 1963
  ident: 2024060106515155800_ehae147-B18
  article-title: Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function
  publication-title: JAMA
  doi: 10.1001/jama.1963.03060120024016
  contributor:
    fullname: Katz
– volume: 204
  start-page: 32
  year: 2023
  ident: 2024060106515155800_ehae147-B26
  article-title: Impact of COVID-19 surge periods on clinical outcomes of transcatheter aortic valve implantation
  publication-title: Am J Cardiol
  doi: 10.1016/j.amjcard.2023.07.072
  contributor:
    fullname: Ryffel
– volume: 30
  start-page: 149
  year: 2017
  ident: 2024060106515155800_ehae147-B6
  article-title: Transcatheter aortic valve implantation in the United States: predictors of early hospital discharge
  publication-title: J Interv Cardiol
  doi: 10.1111/joic.12373
  contributor:
    fullname: Mallikethi-Reddy
– volume: 2
  start-page: 409
  year: 2017
  ident: 2024060106515155800_ehae147-B31
  article-title: Quality-of-life outcomes after transcatheter aortic valve replacement in an unselected population: a report from the STS/ACC Transcatheter Valve Therapy Registry
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2016.5302
  contributor:
    fullname: Arnold
– volume: 15
  start-page: e012168
  year: 2022
  ident: 2024060106515155800_ehae147-B12
  article-title: Economics of minimalist transcatheter aortic valve replacement: results from the 3M-TAVR economic study
  publication-title: Circ Cardiovasc Interv
  doi: 10.1161/CIRCINTERVENTIONS.122.012168
  contributor:
    fullname: Butala
– volume: 21
  start-page: 1573
  year: 2020
  ident: 2024060106515155800_ehae147-B30
  article-title: Very early changes in quality of life after transcatheter aortic valve replacement: results from the 3 M TAVR trial
  publication-title: Cardiovasc Revasc Med
  doi: 10.1016/j.carrev.2020.05.044
  contributor:
    fullname: Lauck
– volume: 96
  start-page: 450
  year: 2020
  ident: 2024060106515155800_ehae147-B11
  article-title: Post-procedure protocol to facilitate next-day discharge: results of the multidisciplinary, multimodality but minimalist TAVR study
  publication-title: Catheter Cardiovasc Interv
  doi: 10.1002/ccd.28617
  contributor:
    fullname: Lauck
SSID ssj0008616
Score 2.5200517
Snippet There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI). The purpose of this...
Abstract Background and Aims There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation...
BACKGROUND AND AIMS: There is significant potential to streamline the clinical pathway for patients undergoing transcatheter aortic valve implantation (TAVI)....
Structured Graphical Abstract BENCHMARK: streamlined transcatheter aortic valve implantation (TAVI) pathway with retained safety. CCU, coronary care unit; ICU,...
SourceID pubmedcentral
hal
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1904
SubjectTerms Aged
Aged, 80 and over
Aortic Valve Stenosis - surgery
Benchmarking
Bioengineering
Clinical Research
Critical Pathways
Europe - epidemiology
Female
Humans
Length of Stay - statistics & numerical data
Life Sciences
Male
Patient Safety
Postoperative Complications - epidemiology
Postoperative Complications - prevention & control
Transcatheter Aortic Valve Replacement - methods
Title A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study
URI https://www.ncbi.nlm.nih.gov/pubmed/38554125
https://www.proquest.com/docview/3022571756/abstract/
https://hal.science/hal-04534032
https://pubmed.ncbi.nlm.nih.gov/PMC11143387
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELa2RUJcEO-GlwziRLV0Ez-ScAulaEXZSkCLeoucxKstgiwKSZH4B_xrZmLHSZYiUS5R1sk6sWcynrG_-UzIM6mKQCNSrYiWYso1yCJWcjb1faZiXUSRbKeyF0dyfsLfnorTyeTXALXU1NmL_OeFeSX_I1UoA7liluwlJOsqhQI4B_nCESQMx3-ScdKmeqiv6CoWSJG6-qEMALPGIailZEUSRLXG_-7Co8815kV-USbhyKE6Xh0c7c8XyYfDAd3s5nQ9bn1d7w7fS9k9343d6nN-XjeVhUuilXWQH9UY0_sRLlaql_RZNfDkLdLYzkMEvMdLdVOTsZhK2W4UDCOLNacQ6sbSEEZ29tb-Mnpl0qOt9QTnhA9GYggl5YVW3jBg6aZqW_4Zz1dK-4a6c8ypvTHWOQSiWXtnqasktVVskStBGAuM4w_f98TzkWx30XWN7BbIY7bnqtizVYxcnK0VAmz_jF42QbgDr-b4BrluwxGaGN26SSa6vEWuLizg4jb5lNCBilGrYhRUjI5UjBoVo62K0aGKvaRwB3UKRlsFu0NO3hwc78-ndiuOac4kr2HMzGJeSBGi-61FLDREyvAxs2AZcQ1OdJixPIvFTOaFzjnLl_lSZcqfSQU9BgV3yXa5LvUOoWgPilxpnukYySYzjGgFU5qFQmeR8MjzrvfSb4ZxJf2rtDzyFPrX3Ydc6fPkXYplEKswPmPBue-RJ133p2A8cUVMlXrdfE8ZeLAiBA9aeuSeEYeriyGAE9x_j0QjQY0eNr5Snq1agnbwHzhjUXj_Mk15QK71n9VDsl1XjX4EDm-dPW5V8TdYl7H8
link.rule.ids 230,315,786,790,891,27957,27958
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+streamlined+pathway+for+transcatheter+aortic+valve+implantation%3A+the+BENCHMARK+study&rft.jtitle=European+heart+journal&rft.au=Frank%2C+Derk&rft.au=Durand%2C+Eric&rft.au=Lauck%2C+Sandra&rft.au=Muir%2C+Douglas+F&rft.date=2024-06-01&rft.issn=0195-668X&rft.eissn=1522-9645&rft.volume=45&rft.issue=21&rft.spage=1904&rft.epage=1916&rft_id=info:doi/10.1093%2Feurheartj%2Fehae147&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_eurheartj_ehae147
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon